Southpoint Capital Advisors LP - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 55 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.

Quarter-by-quarter ownership
Southpoint Capital Advisors LP ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$30,619,877
-14.9%
4,077,2140.0%0.68%
-12.4%
Q2 2023$36,001,800
+6.1%
4,077,2140.0%0.78%
+1.6%
Q1 2023$33,922,420
-13.3%
4,077,2140.0%0.77%
-23.9%
Q4 2022$39,141,254
+18.5%
4,077,2140.0%1.01%
+13.6%
Q3 2022$33,025,000
+45.2%
4,077,2140.0%0.89%
+38.0%
Q2 2022$22,751,000
-0.4%
4,077,2140.0%0.64%
+45.6%
Q1 2022$22,832,000
+27.3%
4,077,2140.0%0.44%
+28.8%
Q4 2021$17,940,000
-53.3%
4,077,2140.0%0.34%
-58.0%
Q3 2021$38,407,000
+29.2%
4,077,2140.0%0.82%
+59.2%
Q2 2021$29,723,000
-41.3%
4,077,214
-50.0%
0.52%
+24.7%
Q1 2021$50,638,000
+66.7%
8,154,428
+100.0%
0.41%
-22.1%
Q4 2020$30,375,000
+22.9%
4,077,2140.0%0.53%
-5.7%
Q3 2020$24,708,000
-27.4%
4,077,2140.0%0.56%
-32.3%
Q2 2020$34,045,000
+43.4%
4,077,214
+2.0%
0.83%
+19.6%
Q1 2020$23,743,000
-8.5%
3,997,2140.0%0.69%
-25.7%
Q4 2019$25,942,000
+34.9%
3,997,2140.0%0.93%
+28.7%
Q3 2019$19,227,000
+20.3%
3,997,2140.0%0.73%
+20.2%
Q2 2019$15,989,000
-17.5%
3,997,2140.0%0.60%
-26.6%
Q1 2019$19,386,000
-24.0%
3,997,2140.0%0.82%
-33.3%
Q4 2018$25,502,000
-22.2%
3,997,2140.0%1.23%
-2.6%
Q3 2018$32,777,000
-21.5%
3,997,2140.0%1.27%
-28.6%
Q2 2018$41,731,000
-13.7%
3,997,2140.0%1.77%
-17.2%
Q1 2018$48,346,000
+20.7%
3,997,2140.0%2.14%
+12.4%
Q4 2017$40,052,000
-9.6%
3,997,2140.0%1.91%
+4.8%
Q3 2017$44,329,0003,997,2141.82%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders